AGA releases updated guidelines on hepatitis B reactivation in patients on immunosuppressive drugs

Cristiana Gigina

American Gastroenterological Association Jan 23 2025 The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive drugs. The use of immunosuppressive drugs has increased significantly since 2013, according to data gathered via the National Health Interview Survey. New tailored risk assessments can help health care

din zilele anterioare